ApniCure is a private Redwood City, Calif.-based medical device company focused on developing and commercializing novel home-use devices incorporating a proprietary platform technology called Oral Pressure Therapy (OPT) for the treatment of obstructive sleep apnea (OSA) and other sleep related disorders. ApniCure has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Winx® Sleep Therapy System in the United States for home-use treatment of OSA. The Winx system is the first in a series of products that ApniCure plans to introduce.
ApniCure aims to improve the lives of the millions of patients suffering from sleep disordered breathing, by providing them with quality, innovative, effective sleep therapies.
Company Growth (employees)